header_aboutUs

Why we give: BMO Financial Group

BMO Financial Group funds research into brain and nerve diseases

In October, BMO Financial Group – a generous supporter of St. Boniface Hospital Foundation for nearly 30 years – announced a $250,000 gift in support of Neurodegenerative Disorders Research.

(From left) Brenda Badiuk, Interim President & CEO, St. Boniface Hospital; Vince Barletta, President & CEO, St. Boniface Hospital Foundation; John MacAulay, Senior Vice President, Prairies and Central Canada Division, BMO Bank of Montreal; Dr. Grant Pierce, Executive Director of Research at St. Boniface Hospital.

At St. Boniface Hospital Albrechtsen Research Centre, the Division of Neurodegenerative Disorders (DND) studies brain and nerve diseases including Alzheimer’s disease, multiple sclerosis, stroke, dementia, nerve damage during diabetes and other life-altering neurological diseases.

“We are so proud to continue our support of St. Boniface Hospital, and help them advance the ground-breaking work they’re doing for DND research,” said John MacAulay, Senior Vice President, Prairies and Central Canada Division, BMO Bank of Montreal. “This gift brings our commitment to the Hospital to almost $1 million, and we could not be more confident that it will make the future of Manitoba and our country a healthier one.”

“In neurodegenerative diseases, the ability of the nervous system to produce energy to support function is impaired,” explained Dr. Paul Fernyhough, Director, Division of Neurodegenerative Disorders, Professor and Head, Department of Pharmacology & Therapeutics, University of Manitoba. “The BMO Financial Group funding will enable novel studies that will identify pathways that are impacted by diabetes and Alzheimer’s disease leading to neurodegeneration. Discovery of these signaling pathways will enhance our knowledge of the cause of brain disease and provide new targets for drug therapy,” he said.

“BMO Financial Group’s gift is offering hope,” said Dr. Grant Pierce, Executive Director of Research at St. Boniface Hospital. “Hope for both the patients suffering from Alzheimer’s disease and Type 1 diabetes, and the families that are slowly watching their loved one fade away. Every step we take is helping bring this research from the bench to the patient at the bedside.”

*This article was first published in the Spring 2018 edition of Believe, St. Boniface Hospital Foundation’s bilingual newsletter produced twice annually in partnership with St. Boniface Hospital.